Journals / Journal of Cellular Neuroscience and Oxidative Stress / 2025 / Volume: 17 Issue: 2

The Oxidative DNA Damage Marker 8-OHdG Indicates No Clear Association to Newly Detected Breast Cancer in Women

Pages
1261–1269
Publication Date
2025-10-07
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our findings suggest that 8-OHdG may not serve as a general screening biomarker for breast cancer, as its levels were comparable across all clinical and pathological parameters examined.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The role of 8-hydroxydeoxyguanosine (8-OHdG) as a biomarker in breast cancer remains controversial with conflicting results across studies.
📊
Key Findings & Data:This case-control study aimed at comparing serum 8-OHdG levels between breast cancer patients and healthy controls, and examine associations with clinical characteristics.
💡
Conclusion & Impact:Our findings suggest that 8-OHdG may not serve as a general screening biomarker for breast cancer, as its levels were comparable across all clinical and pathological parameters examined.
🔬Design:Survey & Empirical Study
📍Scope:2024 Verileri
⚙️Variables:8-hydroxy-2 · breast neoplasms · oxidative stress

Abstract

The role of 8-hydroxydeoxyguanosine (8-OHdG) as a biomarker in breast cancer remains controversial with conflicting results across studies. This case-control study aimed at comparing serum 8-OHdG levels between breast cancer patients and healthy controls, and examine associations with clinical characteristics. Thus, 71 Iraqi women (47 newly diagnosed, treatment-naïve breast cancer patients and 24 controls) were used from November 2024 to June 2025. Demographic data and lifestyle factors were collected through structured questionnaires. No significant difference was found in median 8-OHdG levels between breast cancer patients and controls. No correlations were observed between 8-OHdG and age, BMI, tumor grade, or hormone receptor status. Our findings suggest that 8-OHdG may not serve as a general screening biomarker for breast cancer, as its levels were comparable across all clinical and pathological parameters examined.

🔖

Cite This Article

Al-tameemi, S., Hameed, R., Alqanbar, M. (2025). The Oxidative DNA Damage Marker 8-OHdG Indicates No Clear Association to Newly Detected Breast Cancer in Women. Journal of Cellular Neuroscience and Oxidative Stress, Volume: 17 Issue: 2, 1261–1269. https://doi.org/10.37212/jcnos.1746366

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Al-Tameemi HK, Abdullah DA, Al-Baldawy MT, Abid HA, Al-Saffar OB, Al-Gazali HR (2025). Comprehensive analysis of six biomarkers expression in early-stage breast cancer: A crosssectional study. Dubai Med J. 8: 57–72. https://doi.org/10.18502/dmj.v8i1.18315
  2. Gornitsky M, Velly AM, Mohit S et al. (2016). Altered levels of salivary 8-oxo-7-hydrodeoxyguanosine in breast cancer. JDR Clin Transl Res. 1: 171–177. https://doi.org/10.1177/2380084416642197
  3. Graille M, Wild P, Sauvain J-J, Hemmendinger M, Guseva Canu I, Hopf NB (2020). Urinary 8-OHDG as a biomarker for oxidative stress: A systematic literature review and meta-analysis. Int J Mol Sci. 21: 3743. https://doi.org/10.3390/ijms21113743
  4. Himmetoglu S, Dincer Y, Ersoy YE, Bayraktar B, Celik V, Akcay T (2009). DNA oxidation and antioxidant status in breast cancer. J Investig Med. 57: 720–723. https://doi.org/10.2310/JIM.0b013e3181adfb5b
  5. Huyut Z, Uçar B, Yıldızhan K, Altındağ F, Huyut MT (2024). Effect of abemaciclib and curcumin administration on sex hormones, reproductive functions, and oxidative DNA expression in rats. Biotech Histochem. 99: 339–347. https://doi.org/10.1080/10520295.2024.2389524
  6. Jakovcevic D, Dedic-Plavetic N, Vrbanec D, Jakovcevic A, Jakic-Razumovic J (2015). Breast cancer molecular subtypes and oxidative DNA damage. Appl. Immunohistochem. Mol Morphol. 23: 696–703. https://doi.org/10.1097/PAI.0000000000000135
  7. Jelic MD, Mandic AD, Maricic SM, Srdjenovic BU (2021). Oxidative stress and its role in cancer. J Cancer Res Ther. 17: 22–28. https://doi.org/10.4103/jcrt.JCRT_862_16
  8. Kasai H, Kawai K, Li Y (2008). Analysis of 8-OH-dG and 8-OH-Gua as biomarkers of oxidative stress. Genes Environ. 30: 33–40. https://doi.org/10.3123/jemsge.30.33
  9. Lee K-H, Shu X-O, Gao Y-T et al. (2010). Breast cancer and urinary biomarkers of polycyclic aromatic hydrocarbon and oxidative stress in the Shanghai Women’s Health Study. Cancer Epidemiol Biomarkers Prev. 19: 877–883. https://doi.org/10.1158/1055-9965.EPI-09-1098
  10. Li D, Zhang W, Zhu J et al. (2001). Oxidative DNA damage and 8‐ hydroxy‐2‐deoxyguanosine DNA glycosylase/apurinic lyase in human breast cancer. Mol Carcinog. 31: 214–223. https://doi.org/10.1002/mc.1056
  11. Liu Z, Yi J, Liu F (2021). The expression and significance of 8- hydroxydeoxyguanosine in breast cancer patients’ blood, urine and cancer tissue. Trends Immunother. 5: 36. https://doi.org/10.24294/ti.v5.i2.1.1374
  12. Loft S, Fischer‐Nielsen A, Jeding IB, Vistisen K, Poulsen HE (1993). 8‐hydroxydeoxyguanosine as